Pharmaceutical distributors · Spain

Novartis Farmacéutica

Spanish subsidiary of Swiss pharmaceutical company Novartis, with medicines, research, clinical trials, manufacturing, and programs for health professionals and patients.

About Novartis Farmacéutica

Novartis in Spain

Novartis Farmacéutica, S.A. is the Spanish subsidiary of Novartis, a global pharmaceutical company headquartered in Switzerland. Its website is intended for audiences in Spain, where the company says it has operated for three decades, according to its corporate information.

Therapeutic Areas

The company develops and markets treatments for a range of conditions. Areas highlighted on its website include:

  • Oncology, including prostate, breast, and lung cancer
  • Cardiovascular diseases
  • Multiple sclerosis
  • Neuroendocrine tumors
  • Hematology, including paroxysmal nocturnal hemoglobinuria
  • Advanced therapies

Research and Development

Novartis conducts research and development, including drug-development programs and clinical trials. The company publishes information about its clinical trials and runs initiatives such as Reimagina la Ciencia and the Data Driven Health program.

Manufacturing in Spain

The company lists a manufacturing presence in Spain, including anti-infective production plants and a plant for sterile ophthalmic products.

Resources for Professionals and Patients

NovartisPro is a portal for healthcare professionals, with materials about the therapeutic areas in which the company works. Novartis also develops programs for patients and caregivers, including the Observatory for Informed and Shared Decisions, and partners with IESE on academic awards in health-care management.

Social Responsibility

Its social responsibility programs include La Huella by Novartis, Novartis Access, an initiative against malaria, Better Hearts Better Cities, and Access Accelerated. The company publishes an annual integrated report on its environmental, social, and governance (ESG) performance.

Contact

Novartis offers phone support in Spain at +34 900 353 036 and +34 900 507 036. Media inquiries: novartis.comunicacion@novartis.com. Medical information: medicalinfo.spain@novartis.com.

In brief

Medicines, pharmaceutical research, and clinical trials